Dr. Jacques Balthazart: 2017 AWARDEE FOR THE DANIEL S. LEHRMAN LIFETIME ACHIEVEMENT AWARD

Dr. Jacques Balthazart: 2017 AWARDEE FOR THE DANIEL S. LEHRMAN LIFETIME ACHIEVEMENT AWARD

The Society for Behavioral Neuroendocrinology is pleased to announce that Dr. Jacques Balthazart has been selected as this year’s winner of the Daniel S. Lehrman Lifetime Achievement Award.  Dr. Balthazart embodies the spirit and inspiration of Danny Lehrman, with a career of eminent scholarship and a record of outstanding mentorship of future scientists.

Dr. Jacques Balthazart is Director Emeritus of the Research Group in Behavioral Neurobiology at the GIGA Neurosciences of the University of Liege. His distinguished career has tackled numerous topics in behavioral neuroendocrinology, with a focus on the sexual differentiation of brain and behavior and on the role of brain aromatase in male sexual behavior. He has mentored trainees at all levels that have, themselves, moved on to productive research careers.  Finally, in addition to his numerous edited books, Dr. Balthazart most recently authored the 2010 book entitled, in French, Biologie de l’homosexualité (and translated into English in 2011; The Biology of Homosexuality) summarizing the current knowledge on the biological mechanisms that control sexual orientation in animals and humans, and stimulating open scientific discussion on the subject of sexual orientation.

Related articles

PDC*line Pharma is GMP accredited by the Belgian Federal Agency for Medicines and Health Products (FAMHP) for its Quality Control and Release Activities for PDC*lung, a drug for lung cancer immunotherapy

Liège (Belgium), 21st January 2019. PDC*line Pharma is delighted to announce, that the company is now accredited by the Belgian Federal Agency for Medicines and Health Products (FAMHP) for the Quality Control and Release activities of its anticancer agent PDC*lung, intended for the treatment of patients with lung cancer.  PDC*line Pharma is developing a new

Read more
PDC*line Pharma is GMP accredited by the Belgian Federal Agency for Medicines and Health Products (FAMHP) for its Quality Control and Release Activities for PDC*lung, a drug for lung cancer immunotherapy

First Congress in Health Simulation

The Medical Simulation Center of the University of Liège organizes its first congress in Health Simulation: “Towards evidence-based simulation”. Event will be held on Thursday, March 28th, 2019 in the faculty of medicine amphitheatres of Liège University, located on Sart-Tilman campus. Several themes will be discussed: Evidence-based Innovations and advances in simulation Medical education –

Read more
First Congress in Health Simulation

New University Certificate for clinical trials

The Clinical Sciences Department of the Medicine Faculty of the University of Liège organizes from the academic year 2018-2019 a University Certificate in clinical trials. More information is available in this folder

Read more
New University Certificate for clinical trials